A detailed history of Bruce G. Allen Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 272 shares of CRL stock, worth $51,000. This represents 0.04% of its overall portfolio holdings.

Number of Shares
272
Previous 273 0.37%
Holding current value
$51,000
Previous $56.4 Million 5.0%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$187.96 - $245.29 $187 - $245
-1 Reduced 0.37%
272 $53.6 Million
Q2 2024

Jul 12, 2024

SELL
$206.39 - $268.73 $8,668 - $11,286
-42 Reduced 13.33%
273 $56.4 Million
Q1 2024

Apr 10, 2024

BUY
$203.52 - $273.43 $4,273 - $5,742
21 Added 7.14%
315 $85.3 Million
Q4 2023

Jan 10, 2024

BUY
$164.52 - $238.84 $48,368 - $70,218
294 New
294 $69.5 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.